Palabras clave
Asma
Tabaquismo
COVID-19
SARS-CoV-2
Resumen
Objetivo: Determinar la prevalencia y factores de riesgo asociados al tabaquismo durante el periodo de confinamiento ante la pandemia de COVID-19.
Métodos: Mediante un estudio analítico y transversal se analizaron los datos de 2372 participantes. La recolección de la información se realizó con un cuestionario autoadministrado construido con la herramienta Google Forms, el cual se distribuyó y aplicó a través de correo electrónico y de la plataforma de mensajería privada WhatsApp. La relación entre las variables independientes y la resultante fue determinada a través de regresión logística multivariada.
Resultados: De la población total, 69.3 % fue del sexo femenino, la edad media de 20.11 ± 2.01 años, la prevalencia de asma de 12.2 % y la de tabaquismo activo, de 13.3 %. Una mayor proporción de pacientes con asma fumaba (14.2 versus 13,2 %), en comparación con quienes no padecían asma. La regresión logística multivariante mostró que considerar que COVID-19 no existe y no cumplir con el confinamiento se relacionaron con el tabaquismo en pacientes con asma durante la aplicación del plan de contingencia que representa la pandemia de COVID-19.
Conclusiones: Durante el confinamiento en casa por COVID-19, la prevalencia de tabaquismo es mayor en pacientes con asma comparados con los individuos sin esta enfermedad, los factores que favorecen lo anterior están presentes en el entorno familiar.
Referencias
Campos- Fernandes SS, Ribeiro-de Andrade C, Pinheiro-Caminhas A, Moreira-Camargos PA, Cunha-Ibiapina C. Prevalence of self-reported smoking experimentation in adolescents with asthma or allergic rhinitis. J Bras Pneumol. 2016;42(2):84-87. DOI: 10.1590 / S1806-37562015000000296
WHO coronavirus disease (COVID-19) dashboard [Internet]. Suiza: World Health Organization; c2020. Disponible en: https://covid19.who.int/
Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(2):145-151. DOI: 10.3760/cma.j.issn.0254-6450.2020.02.003
Zheng J. SARS-CoV-2: an emerging coronavirus that causes a global threat. Int J Biol Sci. 2020;16(10):1678-1685. DOI: 10.7150/ijbs.45053
Guan W-j, Liang W-h, Zhao Y, Liang H-R, Chen Z-S, Li Y-M, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):2000547. DOI: 10.1183/13993003.00547-2020
Guo FR. Smoking links to the severity of Covid-19: an update of a meta-analysis. J Med Virol. 2020;92(11);2304-2305. DOI: 10.1002/jmv.25967
Halpin D, Faner R, Sibila O, Badia J, Agusti A. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? Lancet Respir Med. 2020;8(5):436-438. DOI: 10.1016/S2213-2600(20)30167-3
Sunjaya AP, Allida SM, Di Tanna GL, Jenkins CR. Asthma and risk of infection, hospitalization, ICU admission and mortality from COVID-19: Systematic review and meta-analysis. J Asthma. 2021;1-14. DOI: 1080/02770903.2021.1888116
The tobacco atlas [Internet]. Health effects of tobacco. EE. UU.: American Cancer Society; 2020. Disponible en: https://tobaccoatlas.org/
Brake SJ, Barnsley K, Lu W, McAlinden KD, Eapen MS, Sohal SS. Smoking upregulates angiotensin-converting enzyme-2 receptor: a potential adhesion site for novel coronavirus SARS-CoV-2 (Covid-19). J Clin Med. 2020;9(3):841. DOI: 10.3390/jcm9030841
Smith JC, Sausville EL, Girish V, Yuan ML, Vasudevan A, John KM, et al. Cigarette smoke exposure and inflammatory signaling increase the expression of the SARS-CoV-2 receptor ACE2 in the respiratory tract. Dev Cell. 2020;53(5);514-529. DOI: 1016/j.devcel.2020.05.012
Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367(6485):1444-1448. DOI: 10.1126/science.abb2762
Global Initiative for Asthma [internet]. EE. UU.: Global strategy for asthma management and prevention, 2020 . Disponible en: www.ginasthma.org
Adeli M, El-Shareif T, Hendaus MA. Asthma exacerbation related to viral infections: An up to date summary. J Family Med Prim Care. 2019;8(9):2753-2759. DOI: 10.4103/jfmpc.jfmpc_86_19
Rosatom M, Russo L, Mazzocut S, Di Vicenzo A, Fioretto P, Vettor R. Current smoking is not associated with COVID-19. Eur Respir J. 2020;55(6):2001290. DOI: 10.1183/13993003.01290-2020.
CDC COVID-19 Response Team. Coronavirus disease 2019 in children-United States, February 12-April 2, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(14):422-426. DOI: 10.15585/mmwr.mm6914e4
Garg S, Kim L, Whitaker M, O’Halloran A, Cummings C, Holstein R, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019-COVID-NET, 14 States, March 1-30, 2020. MMWR Morb Moral Wkly Rep. 2020;69(15):458-464. DOI: 10.15585/mmwr.mm6915e3.
Vázquez-Nava F, Vázquez-Rodríguez EM, Vázquez-Rodríguez CF, Ortega-Betancourt NV, Castillo-Ruiz O, Rodríguez-Castillejos GC. Risk factors of non-adherence to guidelines for the prevention of COVID-19 among young adults with asthma in a region with a high risk of a COVID-19 outbreak. J Asthma. 2020;57:1-7. DOI: 10.1080/02770903.2020.1818774
Secretaría de Salud de Tamaulipas [Internet]. México: Situación geográfica del coronavirus; 2020. Disponible en: http://coronavirus.tamaulipas.gob.mx/situacion-geografica-del-coronavirus/
Mata-Fernández C, Fernández-Benítez M, Pérez-Miranda M, Guillén-Grima F. Validation of the Spanish version of the Phase III ISAAC questionnaire on asthma. J Invest Allergol Clin Immunol. 2005;15(3):201-210.
Hublet A, de Bacquer D, Boyce W, Godeau E, Schmid H, Vereecken C. Smoking in young people with asthma. J Public Health. 2007;29(4):343-349. DOI: 10.1093/pubmed/fdm047
Vázquez-Nava F, Vázquez-Rodríguez EM, Vázquez-Rodríguez CF, Castillo-Ruiz O, Peinado-Herreros J. Epidemiological profile of smoking and nicotine addiction among asthmatic adolescents. Public Health. 2017;149:49-56. DOI: 10.1016/j.puhe.2017.04.012
Ozamiz-Etxebarria N, Dosil-Santamaria M, Picaza-Gorrochategui M, Idoiaga-Mondragón N. Stress, anxiety, and depression levels in the initial stage of the COVID-19 outbreak in a population sample in the northern Spain. Cad Saude Publica. 2020;36(4):e00054020. DOI: 10.1590/0102-311X00054020
Wood JJ, Drahota A, Sze K, Van Dyke M, Decker K, Fujii C, et al. Brief report: effects of cognitive behavioral therapy on parent-reported autism symptoms in school-age children with high-functioning autism. J Autism Dev Disord. 2009;39(11):1608-1612. DOI: 10.1007/s10803-009-0791-7
Sharma V, Hiremath SS, Gupta VK, Puranik M. Perceptions and factors influencing tobacco use among 15 to 20 year old college students in Bangalore city. Int J Contemp Med Res. 2016;3(9):2676-2680. DOI: 10.4103 / 2319-5932.153560
Zbikowski SM, Klesges RC, Robinson LA, Alfano CM. Risk factors for smoking among adolescents with asthma. J Adolesc Health. 2002;30(4):279-287. DOI: 10.1016/S1054-139X(01)00394-9
Trapl ES, Yoder LD, FrankJ L, Borawski EA, Sattar A. Individual, parental, and environmental correlates of cigar, cigarillo and little cigar use among middle school adolescents. Nicotine Tob Res. 2015;18(5):834e41. DOI: 10.1093/ntr/ntv201
Yi Y, Lagniton PNP, Ye S, Li E, Xu R-H. COVID-19: what has been learned and to be learned about the novel coronavirus disease. Int J Biol Sci. 2020:16(10):1753-1766. DOI:10.7150/ijbs.45134
Zhong B-L, Luo W, Li H-M, Zhang Q-Q, Liu X-G, Li W-T, et al. Knowledge, attitudes, and practices towards COVID-19 among Chinese residents during the rapid rise period of the COVID-19 outbreak: a quick online cross-sectional survey. Int J Biol Sci. 2020;16(10):1745-1752. DOI:10.7150/ijbs.45221
Gimenes-Bonilha A, Ruffino-Netto A, Sicchieri M, Achcar JA, Rodrigues-Júnior AL, Baddini-Martinez J. Correlates of experimentation with smoking and current cigarette consumption among adolescents. J Bras Pneumol. 2014;40(6):634-642. DOI: 10.1590/S1806-37132014000600007
Ren M, Lotfipour S. Nicotine gateway effects on adolescent substance use. West J Emerg Med. 2019:20(5):696-709. DOI: 10.5811/westjem.2019.7.41661
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.
Derechos de autor 2021 Revista Alergia México